Sfoglia per Autore
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis
2003-01-01 Campione, E; Marulli, Gc; Carrozzo, Am; Chimenti, Ms; Costanzo, A; Bianchi, L
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients
2003-01-01 Bianchi, L; Costanzo, A; Carnpione, E; Nistico, S; Chimenti, S
Topical use of valproic acid for the prevention or treatment of skin disorders
2004-01-01 Pelicci Pier, Giuseppe; Minucci, Saverio; Costanzo, A; Chimenti, Sergio; Nistico Steven, Paul; Paolino, Donatella
Meccanismi di trasformazione e di progressione del Melanoma.
2004-01-01 Costanzo, A; Papoutsaki, M; Chimenti, S
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters
2004-01-01 Marinari, B; Costanzo, A; Marzano, V; Piccolella, E; Tuosto, L
Treatment of vitiligo with the 308 nm excimer laser.
2004-01-01 Esposito, M; Soda, R; Costanzo, A; Chimenti, S
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene
2004-01-01 Papoutsaki, M; Lanza, M; Marinari, B; Nistico, S; Moretti, F; Levrero, M; Chimenti, S; Costanzo, A
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors
2004-01-01 Marinari, B; Costanzo, A; Marzano, V; Piccolella, E; Tuosto, L
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases
2004-01-01 Bianchi, L; Orlandi, A; Campione, E; Angeloni, C; Costanzo, A; Spagnoli, Lg; Chimenti, S
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene
2004-01-01 Orlandi, A; Bianchi, L; Costanzo, A; Campione, E; Spagnoli, Lg; Chimenti, S
DNp63 transcription is regulated by p53 and p73 upon DNA damage in keratinocytes
2004-01-01 Papoutsaki, M; Lanza, M; Marinari, B; Chimenti, S; Costanzo, A
NF-KB activation via tyrosine phoshorylation of I-KB-alpha results in the selective modulation of the NF-KB transcriptome and activation of progenitor cells markers
2004-01-01 Moretti, F; Palescandolo, E; Serra, C; Vossio, S; Costanzo, A; Levrero, M
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells
2004-01-01 Lunghi, P; Costanzo, A; Levrero, M; Bonati, A
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides.
2004-01-01 Nisticò, S; Costanzo, A; Saraceno, R; Chimenti, S
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population.
2004-01-01 Giardina, E; Novelli, G; Costanzo, A; Nisticò, S; Bulli, C; Sinibaldi, C; Sorgi, Ml; Chimenti, S; Pallone, F; Taccari, E; Borgiani, P
Differential effects of class I/II versus class III histone deacetylases inhibitors (HDACi) in primary Sezary' cells
2004-01-01 Papoutsaki, M; Scotta, C; Lanza, M; Nistico, S; Marzano, V; Chimenti, S; Costanzo, A
Efficacy and safety of infliximab in the treatment of severe or arthropathic psoriasis: preliminary results
2004-01-01 Costanzo, A; Bianchi, L; Papoutsaki, M; Saraceno, R; Esposito, M; Chimenti, S
Efalizumab
2005-01-01 Costanzo, A; Papoutsaki, M; Chimenti, S
delta EF1 repressor controls selectively p53 family members during differentiation
2005-01-01 Fontemaggi, G; Gurtner, A; Damalas, A; Costanzo, A; Higashi, Y; Sacchi, A; Strano, S; Piaggio, G; Blandino, G
Safety and efficacy study on etanercept in patients with plaque psoriasis
2005-01-01 Costanzo, A; Mazzotta, A; Papoutsaki, M; Chimenti, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile